ILMN

Illumina

$141.07

-4.76 (-3.26%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 10.01.2026
$131.56
(-6.74%)
Strong Buy: 1
Buy: 7
Hold: 8
Sell: 1
Strong Sell: 2
Description:
Illumina, Inc. is a premier global biotechnology company headquartered in San Diego, California, renowned for its pioneering contributions to genomic analysis technologies since its inception in 1998. Specializing in sequencing, genotyping, and gene expression solutions, Illumina caters to diverse sectors including research, clinical diagnostics, and agricultural genomics, thereby playing a vital role in the evolution of personalized medicine. With a steadfast commitment to innovation, the company has solidified its leadership in the genomics arena, facilitating significant advancements in genetic research and diagnostics that enhance human health outcomes on a global scale.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
DIAGNOSTICS & RESEARCH
Address:
5200 ILLUMINA WAY, SAN DIEGO, CA, UNITED STATES, 92122
Fiscal year end:
December
Market capitalization:
$22.4 Billion
EBITDA:
$1.17 Billion
PERatio:
32.7
EPS:
4.46
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.412

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-30%
How much will you get:
$702
Prices dates:
31-12-2015: $186.72 and 31-12-2025: $131.16